相似文献
1
From Studio to Rehab: A Debilitating Form of Anti-HMGCR Myopathy.
Cureus. 2023 Jun 22;15(6):e40825. doi: 10.7759/cureus.40825. eCollection 2023 Jun.
2
Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies.
Muscle Nerve. 2013 Oct;48(4):477-83. doi: 10.1002/mus.23854. Epub 2013 Aug 30.
3
Chronic Anti-HMG-CoA Reductase Positive Necrotizing Myositis With Remote Exposure to Statins.
Cureus. 2023 Jun 17;15(6):e40552. doi: 10.7759/cureus.40552. eCollection 2023 Jun.
4
Anti-HMG-CoA reductase myopathy, an undesirable evolution of statin induced myopathy: a case report.
J Community Hosp Intern Med Perspect. 2019 Feb 11;9(1):33-35. doi: 10.1080/20009666.2019.1571882. eCollection 2019.
5
Autoimmune necrotising myopathy and HMGCR antibodies.
Pract Neurol. 2018 Apr;18(2):151-155. doi: 10.1136/practneurol-2017-001848. Epub 2018 Feb 8.
6
Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy.
Muscle Nerve. 2015 Aug;52(2):196-203. doi: 10.1002/mus.24541. Epub 2015 Jan 6.
7
Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
Joint Bone Spine. 2014 Jan;81(1):79-82. doi: 10.1016/j.jbspin.2013.06.008. Epub 2013 Aug 13.
8
Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
J Clin Neurosci. 2018 Nov;57:13-19. doi: 10.1016/j.jocn.2018.08.010. Epub 2018 Sep 8.
9
Statin-induced necrotizing autoimmune myopathy: an extremely rare adverse effect from statin use.
J Community Hosp Intern Med Perspect. 2019 Dec 14;9(6):503-506. doi: 10.1080/20009666.2019.1702272. eCollection 2019.
10
Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan.
Medicine (Baltimore). 2015 Jan;94(4):e416. doi: 10.1097/MD.0000000000000416.
引用本文的文献
1
Dysphagia: A Case Report of an Atypical Presentation of Statin-Induced Necrotizing Myositis.
Cureus. 2023 Aug 16;15(8):e43587. doi: 10.7759/cureus.43587. eCollection 2023 Aug.
本文引用的文献
1
Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients.
Arthritis Res Ther. 2020 Jan 8;22(1):5. doi: 10.1186/s13075-019-2093-6.
2
A pattern-based approach to the interpretation of skeletal muscle biopsies.
Mod Pathol. 2019 Apr;32(4):462-483. doi: 10.1038/s41379-018-0164-x. Epub 2018 Nov 6.
3
Immune-Mediated Necrotizing Myopathy.
Curr Rheumatol Rep. 2018 Mar 26;20(4):21. doi: 10.1007/s11926-018-0732-6.
4
Anti-HMGCR Myopathy.
J Neuromuscul Dis. 2018;5(1):11-20. doi: 10.3233/JND-170282.
5
Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: a nationwide population-based study.
Rheumatology (Oxford). 2017 May 1;56(5):802-810. doi: 10.1093/rheumatology/kew503.
6
Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity.
Ann Rheum Dis. 2017 Apr;76(4):681-687. doi: 10.1136/annrheumdis-2016-210198. Epub 2016 Sep 20.
7
Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
J Neurol Neurosurg Psychiatry. 2016 Oct;87(10):1038-44. doi: 10.1136/jnnp-2016-313166. Epub 2016 May 4.
8
Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle.
Arthritis Care Res (Hoboken). 2017 Feb;69(2):263-270. doi: 10.1002/acr.22920. Epub 2016 Dec 31.
9
Clinical Features and Treatment Outcomes of Necrotizing Autoimmune Myopathy.
JAMA Neurol. 2015 Sep;72(9):996-1003. doi: 10.1001/jamaneurol.2015.1207.
10
Phenotype standardization for statin-induced myotoxicity.
Clin Pharmacol Ther. 2014 Oct;96(4):470-6. doi: 10.1038/clpt.2014.121. Epub 2014 Jun 4.
Zotero 插件
